The AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.76% inched 0.27% higher to $56.60 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.05% rising 0.13% to 15,181.92 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.43% falling 0.18% to 34,751.32. This was the ADR's second consecutive day of gains. AstraZeneca PLC ADR closed $4.33 below its 52-week high ($60.93), which the company reached on July 12th.
The ADR demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.89% rose 0.29% to $108.08, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.39% fell 0.35% to $217.36, and Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD -0.06% fell 0.60% to $71.33. Trading volume (5.1 M) remained 5.9 million below its 50-day average volume of 11.0 M.